TRPC5 and amyotrophic lateral sclerosis: Riluzole, which is the only Food and Drug Administration (FDA)-approved drug to treat amyotrophic lateral sclerosis, activates TRPC5 with low potency (EC50 = 9.2 μM) but is, at least within the TRPC family, specific for TRPC5.306